Ms Achiraya INK Praisuwan is currently a deputy head of GMDP Inspectorate Unit, Inspection, Compliance and License Enforcement Sub-division, Medicines Regulation Division of the Food and Drug Administration in Thailand. She is a professional pharmacist with a doctor of pharmacy degree from the faculty of pharmaceutical science, Naresuan University, Thailand.
Achiraya has relevant experiences in domestic and overseas GMP inspections, handling of products quality defects, and GDP/GSP inspection at vaccine distribution channels. She has been a speaker on Data Integrity and Data Management at ISPE Thailand Affiliate Seminar, Current Challenges to GxP Compliance at ISPE Philippines Affiliate 2018 Annual Meeting, Regulatory framework on Radiopharmaceuticals: Thailand at Taiwan ASEAN Nuclear Medicine Forum 2019, Global GMP Trends – current initiatives, trends, best practices: GMP inspection master class part I at The IV All Russia GMP Conference with international participation 2019, GMP assessment approaches in post COVID-19 era at 2022 AKGMP Inspector Training and Conference.
She has been a principle investigator on a WHO-USP Project on Quality of Antimalarial Medicines in the GMS Countries, a Temporary Advisor to WHO on the national regulatory authority observed audit in India, WHO benchmarking of the national regulatory authority (NRA) in Viet Nam and member of Working group for Development of Performance Evaluation Framework of WHO Listed Authority (WLA): Licensing and Regulatory function, PIC/S Ad Hoc Support Group on Soft Skills. She is a subject matter expert for the International Atomic Energy Agency; IAEA) Technical Working Group on Radiopharmaceutical Medicines Regulations (TWG-RPhR) for a four-year term from 2024 to 2028.
Session objectives:
